EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
  2.1.1.85 | Carcinogenesis |
32042016 |
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells. |
therapeutic application
unassigned |
1
0 |
| 2.1.1.85 | Carcinoma |
32042016 |
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells. |
therapeutic application
unassigned |
1
0 |
| 2.1.1.85 | Dystocia |
30626964 |
SETD3 is an actin histidine methyltransferase that prevents primary dystocia. |
therapeutic application
unassigned |
1
0 |
| 2.1.1.85 | Encephalitis, Viral |
31527793 |
Enterovirus pathogenesis requires the host methyltransferase SETD3. |
therapeutic application
unassigned |
1
0 |
| 2.1.1.85 | Myelitis |
31527793 |
Enterovirus pathogenesis requires the host methyltransferase SETD3. |
therapeutic application
unassigned |
1
0 |
| 2.1.1.85 | Neoplasms |
30236198 |
[NSD3 suppresses LPS-triggered TNF-? production via promoting the dimethylation of histone H3K36 in macrophages]. |
unassigned |
0 |
| 2.1.1.85 | Neoplasms |
34469831 |
A NSD3-targeted PROTAC suppresses NSD3 and cMyc oncogenic nodes in cancer cells. |
unassigned |
0 |
| 2.1.1.85 | Uterine Cervical Neoplasms |
31235251 |
SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
3
3
0 |
| 2.1.1.85 | Virus Diseases |
31527793 |
Enterovirus pathogenesis requires the host methyltransferase SETD3. |
therapeutic application
unassigned |
1
0 |
